Scleroderma autoantibodies in guiding monitoring and treatment decisions
Sign Up to like & getrecommendations! Published in 2022 at "Current Opinion in Rheumatology"
DOI: 10.1097/bor.0000000000000904
Abstract: Purpose of review One of the key clinical challenges of systemic sclerosis (SSc) is diversity in clinical presentation, organ involvement and disease progression. Antinuclear autoantibodies (ANA) are central to the diagnosis of SSc. ANA specificities… read more here.
Keywords: guiding monitoring; monitoring treatment; autoantibodies guiding; monitoring ... See more keywords